Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 4Teen4, Abcellera, Affimed, Alligator, Arch, Arrowhead, Centogene, Claritas, Cordenpharma, Cytodyn, Diamyd, Empirico, Ensysce, GL Rapha, Macrogenics, Nanoview, Nouscom, Pharmapark, Prestige, Probiogen, Proteona, RDIF, Recro, Revolo, Stemsynergy, Sutro, Takada, Telara, Xoma.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abivax, Adlai, Afyx, Aligos, Anji, Biolinerx, Biomarin, Chinook, Covis, Ideaya, Immunic, Inflarx, Longeveron, Merck & Co., Novavax, Noxxon, Panbela, Qlaris, Recce, Regenxbio, Regulus, Ridgeback, Roche, SK, Urovant.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agilent Technologies, ATMPS, Biolq, Biostem Technologies, Blue Cross Blue Shield of Massachusetts, Canon Medical, Cloud Dx, Consonance-HFW, D8 Holdings, EBR Systems, Emblemhealth, Fionet, Geninus, Helixrus, Implicity, Mindmaze Healthcare, MLU Services, Ori Biotech, Powerdot, PPD, Procept Biorobotics, Raysearch, Relay Medical, Resolution Bioscience, Rosalind, Soliton, Surrozen, Therabody, Thermo Fisher Scientific, Vicarious Surgical.

The latest global regulatory news, changes and updates affecting biopharma, including: WHO: Antibiotic pipeline nearly static, Canada creates new drug safety net, CDSCO provides guidance on COVID-19 vaccines.

“There is a big need for a drug in outpatients. If you could treat them and keep them out of hospitals, that would be important and play a big role in getting us through this pandemic,” Romark Laboratories LC’s CEO, Marc Ayers, told BioWorld.

More than a quarter of all biopharma/nonprofit deals and grant awards in 2021, as well as 79% of the disclosed funding, targets the COVID-19 pandemic, following a trend that began in the early months of last year as SARS-CoV-2 reared its ugly head.

The latest global regulatory news, changes and updates affecting biopharma, including: FDA provides guidance on remote evaluations.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alimera, Amgen, Aquavit, Ardelyx, Atyr, Aura, Auris, Bioage, Biocryst, Bio-Techne, Boehringer Ingelheim, Cleveland Biolabs, Everon, Genome Protection, Hemogenyx, Huons, Immunicum, Innovation, Kyowa Kirin, Lonza, Merck & Co., Ocumension, Organicell, Polyneuron, Protokinetix, Rubryc, Stridebio, Taysha, Tilt, Torii, Xencor, Zai.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Achieve Life Sciences, Agenus, Aligos, Ardelyx, Ascletis, Astrazeneca, Auris, Endo, Galectin, Gannex, Innocoll, Kyowa Kirin, Moderna, Nervgen, Orphomed, Proqr, Rocket, Romark, Synthetic Biologics and Veracyte.